Endo is taking advantage of June’s status as Men’s Health Month to encourage men to prioritize their physical, mental and sexual health. More: Endo maps out Men’s Health Month awareness, education drive Source: fierce
read more
New guidance expands treatment options for eligible patients More: NICE recommends mirikizumab for Crohn’s disease treatment Source: News
read more
Updated guidance from NICE expands eligibility for dapagliflozin us More: AstraZeneca’s Forxiga recommended for chronic kidney disease treatment Source: News
read moreIn late April, when Sanofi revealed that it was selling a controlling stake in its consumer health business Opella for 10 billion euros, chief financial officer Francois Roger said that the French drugmaker would “explore external growth opportunities for bolt-on acquisitions.” Just
read moreIn The Top Line podcast, Reverba Global CEO Cheryl Lubbert explains how blending data with real-world narratives can rebuild trust and improve patient outcomes. More: Science-led storytelling takes center stage in pharma communications Source: fierce
read moreTheravance estimates that its lifetime earnings from GSK’s inhaler Trelegy, born out of a 2002 collab, total $1.52 billion. More: Theravance hands off the last of its Trelegy royalties to GSK for 5M Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals